EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The gut microbiota and gut–brain axis in Alzheimer’s disease: From pathogenesis to treatment

Jingyi Wang, Lyu Luo, Jiawei Zhang, Lili Yu, Lili Cui

Ageing Research Reviews · 2026-11 · 122 · 103345

DOI: 10.1016/j.arr.2026.103345 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-11. Verfasst von Jingyi Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chinese Medicine, Medical Sciences Division, Macau University of Science and Technology, 999078, Macao Special Administrative Region of Ch…. Hauptthemen laut MEDLINE: Alzheimer Disease, Gastrointestinal Microbiome, Brain, Brain-Gut Axis. Die Arbeit nennt 77 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a progressive neurodegenerative disorder whose pathological course involves amyloid-β (Aβ) deposition, tau abnormalities, neuroinflammation, and neurovascular dysfunction. Interest in the microbiota-gut-brain axis does not arise because gut dysbiosis has been established as an independent initiating cause of sporadic AD, but because this axis connects modifiable peripheral factors-including diet, medication, ageing, and intestinal physiology-with barrier homeostasis, immunometabolic state, neural afferent signaling, and the brain's response to pathology. Human studies have detected microbiota differences in biomarker-positive preclinical AD and suggest that barrier abnormalities may be associated with subsequent cognitive change; patient-derived microbiota transfer, APOE-dependent tau models, and immune-vagal circuit studies further support phenotype modifiability under defined experimental conditions. This review therefore integrates barrier, immune, metabolic, and neural pathways and emphasizes that diverse microbial alterations may converge on a limited set of measurable functional nodes that could be more informative than individual genera for mechanistic validation, risk stratification, and treatment monitoring. Although clinical intervention evidence remains at an early stage, the peripheral accessibility and modifiability of the microbiota provide a rationale for investigating it as an adjunctive target alongside standard AD therapy. Future work should concurrently evaluate the microbiome, metabolites, both barriers, and immune and neural readouts in longitudinal cohorts and stratified randomized trials to determine which patients, disease stages, and intervention modalities are most likely to benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseGastrointestinal MicrobiomeBrainBrain-Gut AxisHumansAnimalsDysbiosis

Stichwörter der Autor:innen

Alzheimer’s diseaseFecal microbiota transplantationGut microbiotaGut–brain axisNeuroinflammationProbiotics

Autor:innen und Institutionen

  • Faculty of Chinese Medicine, Medical Sciences Division, Macau University of Science and Technology, 999078, Macao Special Administrative Region of China.
  • Institute of Neurology, Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524000, China.
  • The Marine Biomedical Research Institute of Guangdong, School of Ocean and Tropical Medicine, Guangdong Medical University, Zhanjiang, 524000, China.
  • Faculty of Chinese Medicine, Medical Sciences Division, Macau University of Science and Technology, 999078, Macao Special Administrative Region of China. Electronic address: llyu@must.edu.mo.
  • Institute of Neurology, Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524000, China; The Marine Biomedical Research Institute of G…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, J., Luo, L., Zhang, J., Yu, L., & Cui, L. (2026). The gut microbiota and gut–brain axis in Alzheimer’s disease: From pathogenesis to treatment. Ageing Research Reviews, 122, 103345. https://doi.org/10.1016/j.arr.2026.103345

Vancouver

Wang J, Luo L, Zhang J, Yu L, Cui L. The gut microbiota and gut–brain axis in Alzheimer’s disease: From pathogenesis to treatment. Ageing Research Reviews. 2026;122:103345. doi:10.1016/j.arr.2026.103345

BibTeX
@article{Wang2026,
  author = {Wang, Jingyi and Luo, Lyu and Zhang, Jiawei and Yu, Lili and Cui, Lili},
  title = {The gut microbiota and gut–brain axis in Alzheimer’s disease: From pathogenesis to treatment},
  journal = {Ageing Research Reviews},
  year = {2026},
  volume = {122},
  pages = {103345},
  doi = {10.1016/j.arr.2026.103345}
}
Kostenlos starten →